Endometriosis, commonly known as fibroids is the cause of distress among many women in the early ages of their reproductive cycle.
Many treatments exist in the current system of medication but are limited by the severe side effects.
Researchers at the San Diego School of Medicine have come up with a new drug – Elagolix that promises to not only provide relief from the pain that accompanies the disease but also freedom from its symptoms.
Information about Endometriosis
Endometriosis is a gynecological disorder where the cells lining the uterus grow in other parts of the body. It is the number one reason for hysterectomy among women aged between 18 to 35 years.
Surgical remedies are not without risk, especially given the age group. Relief from medication includes injections to reduce the estrogen levels. But these cause severe side effects ranging from physical to mental. Osteoporosis is a common side effect of these injections. As a result, many patients are under secondary treatments to deal with the side effects alone. This continues until menopause.
The New Drug
Elagolix is the answer from Abbott to all problems associated with endometriosis. The research has been labeled The Violet Petal Study. The main USP of this drug is that the medication has achieved the right level of estrogen optimization for the normal functioning of the patient’s reproductive system. A daily dosage of Elagolix is said to reduce the estrogen levels just so that the pain is relieved. This means no side effects and secondary treatments. Clinical trials have entered the third phase and are providing promising results.
Once released, this new drug is said to be one of the wonder drugs in the field of gynecology as it can prevent the rising rates of hysterectomy among young women all over the world.
